SynopsisMarket Analysis and Insights: Global Thrombolytic Therapy Market The thrombolytic therapy market covers drug treatment, surgical treatment, etc. The typical players include Roche, Taj Pharmaceuticals, Genentech, etc. The global Thrombolytic Therapy.....
Synopsis Global Angiography Devices market is projected to reach US$ 10340 million in 2029, increasing from US$ 7518.5 million in 2022, with the CAGR of 4.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 .....
SynopsisEtravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs doe.....
SynopsisInactivated polio vaccine (IPV) IPV is produced from wild-type poliovirus strains of each serotype that have been inactivated (killed) with formalin. The global Poliovirus Vaccine Inactivated market was valued at US$ 688.5 million in 2023 and is anticipa.....
SynopsisInfusion Accessories & Consumables assist infuses fluids, medication or nutrients into a patient's circulatory system. It is generally used intravenously, although subcutaneous, arterial and epidural infusions are occasionally used. The global Infusion A.....
SynopsisDue to the COVID-19 pandemic, the global Schistosomiasis Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic cha.....
SynopsisClofarabine is a purine nucleoside antimetabolite marketed in the US and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. The global Clolar market size is expected to reach US$ 663 million by 2029, gro.....
SynopsisColposcope is a medical diagnostic procedure to examine an illuminated, magnified view of the cervix and the tissues of the vagina and vulva. Many premalignant lesions and malignant lesions in these areas have discernible characteristics which can be detected .....
SynopsisThe global Personal Genome Testing market size is expected to reach US$ 3178.8 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Personal Genome Testing in various end use industries. T.....
SynopsisMAOIs are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are widely used as anti-depressants. The global Monoamine Oxidase Inhibitor (MAOIs) market wa.....
